Head-to-head · Cost-Efficiency Index
Rewinding RX vs Primary Clinic (Direct GLP)
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rewinding RX
Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line.
Visit Rewinding RXPrimary Clinic (Direct GLP)
Shoppers inside its 10 served states who want primary care bundled with the prescription and will price the membership in.
Visit Primary Clinic (Direct GLP)The verdict
Rewinding RX takes it, leading the Cost-Efficiency Index 66 to 65. Rewinding RX (Rewinding RX Ltd.) is a longevity-framed telehealth platform selling FOUR distinct GLP-1 products: standard-dose semaglutide ($139/mo) and tirzepatide ($189/mo). Primary Clinic (Direct GLP) still earns a C — Shoppers inside its 10 served states who want primary care bundled with the prescription and will price the membership in.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Rewinding RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rewinding RX | Primary Clinic (Direct GLP) |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 65/100 |
| Semaglutide / mo | $139/mo (microdose tier, compounded) | $85/mo (0.25-0.75 mg band, membership required, compounded) |
| Tirzepatide / mo | $189/mo (microdose tier, compounded) | $133/mo (1.25-2.5 mg band, membership required, compounded) |
| Semaglutide / yr (modeled) | $1,668 | $1,020 |
| Tirzepatide / yr (modeled) | $2,268 | $1,596 |
| Coverage | All 50 states | WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #140 | #146 |
Rewinding RX
66/100Where the value is
- Flat pricing within each product regardless of dose
- Publishes the FDA compounded-medication disclaimer and states pharmacies are '503A'/'503B' FDA-regulated facilities
- Corporate entity is disclosed (Rewinding RX Ltd.)
The tradeoffs
- Four separate GLP-1 SKUs exist at four different prices under similar names
- No compounding pharmacy is individually named, only generic '503A'/'503B' language
Primary Clinic (Direct GLP)
65/100Where the value is
- Both molecules are priced, as dose bands, so the cost of titrating up is visible rather than hidden
- The $89 membership buys unlimited primary care, direct text access and same-day appointments, not just a prescription
- Real per-dose pricing rather than one headline rate
The tradeoffs
- The medication price is on top of an $89/mo membership, which the FAQ states does not include the drug — all-in is about $174/mo semaglutide and $222/mo tirzepatide
- Prices are published as dose BANDS, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labeled starting dose
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.